2-HYDROXY-2-(3,4-DICHLOROPHENYL)ETHYLAMINE OXALATE, 95.0%, 1g

N,N-dimetilformamida, min 99,5%, para síntesis, 1L, envase de vidrio

1-(4-ETHYLPHENYL)-3-PHENYLUREA, 95%, 25mg

(2-Methylpyrimidin-5-yl)methanol, 97.0%, 1g

3,3-Dimethyl-2-pentanone, 99.0%, 25g

tert-Butyl (3R,4S)-4-amino-3-hydroxypiperidine-1-carboxylate, 97%, 1g

Ethyl 2-bromo-4H-pyrrolo[2,3-d]thiazole-5-carboxylate, 95%, 1g

2-(Methoxymethyl)pyrimidin-5-ol, 98%, 500mg

1-(Benzylamino)propan-2-ol, 97%, 1g

4-(Benzylaminomethyl)-2-methoxyphenol, 1g

ETHYL 2-(3-METHYL-4-OXO-3,4-DIHYDROPHTHALAZIN-1-YL)ACETATE, 95.0%, 500mg

2-{[(2-fluorophenyl)sulfonyl]amino}-3-methylbutanoic acid, 95.0%, 1g

1-(2,4-Dichloro-phenoxymethyl)-1 H -pyrazole-3-carboxylic acid, 50mg